Matches in Nanopublications for { ?s ?p "[In order to understand the contribution of SHOC2 mutations to the clinical manifestations of Noonan syndrome and related disorders, we analyzed SHOC2 in 92 patients with Noonan syndrome and related disorders who did not exhibit PTPN11, KRAS, HRAS, BRAF, MAP2K1/2, SOS1 or RAF1 mutations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 3 of
3
with 100 items per page.
- NP236284.RAHURpjHIZVxsg3A9PHszrZUfC-JmgswouSY2GPk3Vf5U130_assertion description "[In order to understand the contribution of SHOC2 mutations to the clinical manifestations of Noonan syndrome and related disorders, we analyzed SHOC2 in 92 patients with Noonan syndrome and related disorders who did not exhibit PTPN11, KRAS, HRAS, BRAF, MAP2K1/2, SOS1 or RAF1 mutations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP236284.RAHURpjHIZVxsg3A9PHszrZUfC-JmgswouSY2GPk3Vf5U130_provenance.
- assertion description "[In order to understand the contribution of SHOC2 mutations to the clinical manifestations of Noonan syndrome and related disorders, we analyzed SHOC2 in 92 patients with Noonan syndrome and related disorders who did not exhibit PTPN11, KRAS, HRAS, BRAF, MAP2K1/2, SOS1 or RAF1 mutations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP842733.RA3-UMjTx62Zr0UR3FGHrrDtH3p1fgiteoT_Kog8zX1tY130_assertion description "[In order to understand the contribution of SHOC2 mutations to the clinical manifestations of Noonan syndrome and related disorders, we analyzed SHOC2 in 92 patients with Noonan syndrome and related disorders who did not exhibit PTPN11, KRAS, HRAS, BRAF, MAP2K1/2, SOS1 or RAF1 mutations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP842733.RA3-UMjTx62Zr0UR3FGHrrDtH3p1fgiteoT_Kog8zX1tY130_provenance.